Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 5:59 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 793–816 of 1,418 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Fluid administration Clear all

Conditions: Obstructive Sleep Apnea
Interventions: Lumbar Puncture (Standard-of-Care); Procedure
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 50 Years to 84 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Depemokimab, Placebo; Biological · Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 981 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 42
States / cities: Bakersfield, California • Modesto, California • Newport Beach, California + 34 more

Conditions: Pleural Diseases
Interventions: Chest thoracoscopy, Chest fibrinolytic therapy, tPA, DNase; Procedure · Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 90 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Insulin Sensitivity, Obesity
Interventions: Cold exposure, Cold exposure plus propranolol, Thermoneutral Conditions, Cold water consumption, Tepid water consumption, Exercise, Meal consumption; Other
Lead sponsor: Rutgers University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Pain
Interventions: Zipsor®; Drug
Lead sponsor: Depomed; Industry
Eligibility: 12 Years to 17 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 2
States / cities: Sheffield, Alabama • Stanford, California

Conditions: Fibrodysplasia Ossificans Progressiva
Interventions: Garetosmab, Placebo; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2029
U.S. locations: 2
States / cities: Los Angeles, California • Nashville, Tennessee

Conditions: Critical Illness, Acidosis, Metabolic
Interventions: Lactated Ringer's, Normosol; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 2,093 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Obesity, Type 2 Diabetes Mellitus, Insulin Resistance
Interventions: Gastric bypass, Gastric banding, Sleeve gastrectomy, Very low calorie diet; Procedure · Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 119 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Autism, Autism Spectrum Disorder
Interventions: Charades based mobile digital therapeutic; Device
Lead sponsor: Stanford University; Other
Eligibility: 3 Years to 12 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Bladder Cancer
Interventions: standard fluid management, fluid management guided by the EV1000; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 21 Years and older
Enrollment: 282 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2024
U.S. locations: 5
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Commack, New York + 2 more

Conditions: Healthy Volunteers
Interventions: [14C]-BGB-11417; Drug
Lead sponsor: BeiGene; Industry
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Overactive Bladder
Interventions: Behavioral training, Oxybutynin chloride, extended-release; Behavioral · Drug
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 19 Years and older · Male only
Enrollment: 143 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 2
States / cities: Birmingham, Alabama • Decatur, Georgia

Conditions: Kidney Transplant, Fluid Management
Interventions: Phenotype-Guided Vasoactive Management; Drug
Lead sponsor: Jennifer Cutler; Other
Eligibility: 18 Years and older
Enrollment: 255 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Post-COVID Postural Orthostatic Tachycardia Syndrome
Interventions: IgPro20, Placebo; Biological
Lead sponsor: CSL Behring; Industry
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 34
States / cities: Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 29 more

Conditions: Open Heart Surgery
Interventions: CRUISE CTICU CareTaker Vitalstream Device, CRUISE CTICU CNAP Device, CRUISE CTICU Edwards Clearsight Device; Device
Lead sponsor: Hernando Gomez; Other
Eligibility: 18 Years to 105 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Verruca Vulgaris
Interventions: Liquid Nitrogen Cryotherapy, Pulsed 1064nm Nd:YAG; Procedure
Lead sponsor: Trinity Health Michigan; Other
Eligibility: 18 Years to 75 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Ypsilanti, Michigan

Conditions: Chronic Kidney Disease
Interventions: Calcium acetate oral solution (COS), Sevelamer carbonate; Drug
Lead sponsor: Fresenius Medical Care North America; Industry
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 4
States / cities: New Haven, Connecticut • North Haven, Connecticut • New York, New York

Conditions: Abortion, Dilation and Evacuation, Hemorrhage, Blood Loss
Interventions: intravenous oxytocin, Intravenous Fluids and Electrolytes; Drug
Lead sponsor: University of Hawaii; Other
Eligibility: 14 Years to 50 Years · Female only
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 2
States / cities: Honolulu, Hawaii • Seattle, Washington

Conditions: CKD, ESRD
Interventions: Long term hemodialysis catheter; Device
Lead sponsor: Medical Components, Inc dba MedComp; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Autism Spectrum Disorder, Autism
Interventions: GuessWhat Mobile Application; Other
Lead sponsor: Stanford University; Other
Eligibility: 3 Years to 12 Years
Enrollment: 186 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Stanford, California

Conditions: Heart Failure, Dilated Cardiomyopathy
Interventions: clenbuterol; Drug
Lead sponsor: Francis D. Pagani; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 7
States / cities: Washington D.C., District of Columbia • Chicago, Illinois • Ann Arbor, Michigan + 4 more

Conditions: Pain
Interventions: Ondansetron; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 70 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Benign Prostatic Hyperplasia
Interventions: UroLift; Device
Lead sponsor: NeoTract, Inc.; Industry
Eligibility: 45 Years and older · Male only
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Heart Failure
Interventions: Heart Failure Management Intervention; Device
Lead sponsor: Bodyport Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Search by objective public record fields.

A Pilot Study of Biomarkers in Obstructive Sleep Apnea

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

Fibrinolytic Therapy Versus Medical Thoracoscopy

The Effect of Brown Adipose Tissue Activation on Insulin Sensitivity in Humans

Safety and Tolerability of Zipsor® in Pediatric Subjects (Ages 12-17 Years) With Mild to Moderate Acute

A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP)

Balanced Solutions and Plasma Electrolytes

Changes in Insulin Sensitivity After Weight Loss

Evaluating Efficacy of a Digital Game Therapeutic for Children With Autism

A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy

A Study to Investigate the Absorption, Metabolism and Excretion of [14C]-BGB-11417

Behavioral Treatment of Overactive Bladder in Men

Phenotype Guided Vasoactive Medication During Kidney Transplantation

Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTS

CTICU Device Study CRUISE

Pulsed 1064nm Nd:YAG in the Treatment of Verruca Vulgaris Versus Conventional Therapy With Liquid Nitrogen Cryotherapy

Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients

Effects of Oxytocin on Bleeding Outcomes During Dilation and Evacuation

Long Term Hemodialysis Catheters (LTHD) Post Market Clinical Follow up (PMCF)

Piloting a Mobile Game for Behavioral Therapy

Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure

CSF Pharmacokinetics of Ondansetron

Urodynamic Feasibility Study Utilizing the UroLift® System

Fluid Guided Heart Failure Treatment at the Cleveland Clinic